Literature DB >> 23313378

(-)-Xanthatin up-regulation of the GADD45γ tumor suppressor gene in MDA-MB-231 breast cancer cells: role of topoisomerase IIα inhibition and reactive oxygen species.

Shuso Takeda1, Momoko Noguchi, Kazumasa Matsuo, Yasuhiro Yamaguchi, Taichi Kudo, Hajime Nishimura, Yoshiko Okamoto, Toshiaki Amamoto, Mitsuru Shindo, Curtis J Omiecinski, Hironori Aramaki.   

Abstract

Previously, we reported that (-)-xanthatin, a naturally occurring xanthanolide present in the Cocklebur plant, exhibits potent anti-proliferative effects on human breast cancer cells, accompanied by an induction of the growth arrest and DNA damage-inducible gene 45γ (GADD45γ), recognized recently as a novel tumor suppressor gene. However, the mechanisms mediating this activation were unknown. Topoisomerase IIα (Topo IIα) inhibition has been reported to produce a cell death response accompanied by an atypical DNA laddering fragmentation profile, similar to that noted previously for (-)-xanthatin. Therefore we hypothesized that (-)-xanthatin's GADD45γ activation was mediated through the Topo IIα pathway. Here, we identify that (-)-xanthatin does function as a catalytic inhibitor of Topo IIα, promoting DNA damage. In addition, reactive oxygen species (ROS) were elevated in cells treated with this agent. Mechanistically, it was determined that the induced levels of GADD45γ mRNA resulting from (-)-xanthatin exposures were stabilized by coordinately produced ROS, and that the consequent induction of GADD45γ mRNA, GADD45γ protein and ROS generation were abrogated by co-treatment with N-acetyl-l-cysteine. Taken together, the data support the concept that Topo IIα inhibition by (-)-xanthatin is a trigger that stimulates expression of DNA damage-inducible GADD45γ mRNA and that concomitantly produced ROS act downstream to further enhance the GADD45γ mRNA/GADD45γ protein induction process, resulting in breast cancer cell death.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23313378      PMCID: PMC4030303          DOI: 10.1016/j.tox.2012.12.019

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  40 in total

1.  Stimulation of topoisomerase II-mediated DNA damage via a mechanism involving protein thiolation.

Authors:  H Wang; Y Mao; A Y Chen; N Zhou; E J LaVoie; L F Liu
Journal:  Biochemistry       Date:  2001-03-20       Impact factor: 3.162

2.  Secondary metabolites in the genus Sticta (lichens).

Authors: 
Journal:  Biochem Syst Ecol       Date:  2000-07-01       Impact factor: 1.381

3.  The role of polyamine catabolism in polyamine analogue-induced programmed cell death.

Authors:  H C Ha; P M Woster; J D Yager; R A Casero
Journal:  Proc Natl Acad Sci U S A       Date:  1997-10-14       Impact factor: 11.205

4.  Cell cycle-dependent DNA damage signaling induced by ICRF-193 involves ATM, ATR, CHK2, and BRCA1.

Authors:  Iha Park; Hava Karsenty Avraham
Journal:  Exp Cell Res       Date:  2006-04-21       Impact factor: 3.905

5.  Genotoxicity of several clinically used topoisomerase II inhibitors.

Authors:  G Boos; H Stopper
Journal:  Toxicol Lett       Date:  2000-07-27       Impact factor: 4.372

Review 6.  What made sesquiterpene lactones reach cancer clinical trials?

Authors:  Akram Ghantous; Hala Gali-Muhtasib; Heikki Vuorela; Najat A Saliba; Nadine Darwiche
Journal:  Drug Discov Today       Date:  2010-06-09       Impact factor: 7.851

7.  Activation of topoisomerase II-mediated excision of chromosomal DNA loops during oxidative stress.

Authors:  T K Li; A Y Chen; C Yu; Y Mao; H Wang; L F Liu
Journal:  Genes Dev       Date:  1999-06-15       Impact factor: 11.361

8.  The cytoprotective effect of N-acetyl-L-cysteine against ROS-induced cytotoxicity is independent of its ability to enhance glutathione synthesis.

Authors:  Fengjiao Zhang; Serrine S Lau; Terrence J Monks
Journal:  Toxicol Sci       Date:  2010-12-06       Impact factor: 4.849

9.  Sodium salicylate is a novel catalytic inhibitor of human DNA topoisomerase II alpha.

Authors:  Jason T Bau; Ebba U Kurz
Journal:  Biochem Pharmacol       Date:  2010-10-17       Impact factor: 5.858

10.  Xanthatin induces cell cycle arrest at G2/M checkpoint and apoptosis via disrupting NF-κB pathway in A549 non-small-cell lung cancer cells.

Authors:  Lei Zhang; Junshan Ruan; Linggeng Yan; Weidong Li; Yu Wu; Li Tao; Feng Zhang; Shizhong Zheng; Aiyun Wang; Yin Lu
Journal:  Molecules       Date:  2012-03-26       Impact factor: 4.411

View more
  6 in total

Review 1.  How Should the Worldwide Knowledge of Traditional Cancer Healing Be Integrated with Herbs and Mushrooms into Modern Molecular Pharmacology?

Authors:  Yulia Kirdeeva; Olga Fedorova; Alexandra Daks; Nikolai Barlev; Oleg Shuvalov
Journal:  Pharmaceuticals (Basel)       Date:  2022-07-14

2.  A Novel Nanoparticle Preparation to Enhance the Gastric Adhesion and Bioavailability of Xanthatin.

Authors:  Yaqian Zhou; Xingyu Zhu; Shangyang Lin; Chenqi Zhu; Li Wu; Rui Chen; Zhipeng Chen; Weidong Li
Journal:  Int J Nanomedicine       Date:  2020-07-14

3.  Δ(9)-Tetrahydrocannabinol disrupts estrogen-signaling through up-regulation of estrogen receptor β (ERβ).

Authors:  Shuso Takeda; Kazutaka Yoshida; Hajime Nishimura; Mari Harada; Shunsuke Okajima; Hiroko Miyoshi; Yoshiko Okamoto; Toshiaki Amamoto; Kazuhito Watanabe; Curtis J Omiecinski; Hironori Aramaki
Journal:  Chem Res Toxicol       Date:  2013-06-11       Impact factor: 3.739

Review 4.  Natural Compounds as Anticancer Agents Targeting DNA Topoisomerases.

Authors:  Chetan Kumar Jain; Hemanta Kumar Majumder; Susanta Roychoudhury
Journal:  Curr Genomics       Date:  2017-02       Impact factor: 2.236

5.  Xanthatin induces glioma cell apoptosis and inhibits tumor growth via activating endoplasmic reticulum stress-dependent CHOP pathway.

Authors:  Yu-Yang Ma; Ze-Min Di; Qing Cao; Wen-Shuang Xu; Si-Xing Bi; Ji-Shuang Yu; Yu-Jun Shen; Yong-Qiang Yu; Yu-Xian Shen; Li-Jie Feng
Journal:  Acta Pharmacol Sin       Date:  2019-11-07       Impact factor: 6.150

6.  (-)-Xanthatin as a Killer of Human Breast Cancer MCF-7 Mammosphere Cells: A Comparative Study with Salinomycin.

Authors:  Shuso Takeda; Masayo Hirao-Suzuki; Mitsuru Shindo; Hironori Aramaki
Journal:  Curr Issues Mol Biol       Date:  2022-08-25       Impact factor: 2.976

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.